All Articles

German lawyers react to “far-reaching” draft amendment

German lawyers react to “far-reaching” draft amendment

28 January 2020

Draft amendments to Germany’s competition law will result in “big changes” for the national competition authority and give the enforcer “powerful new tools”, local lawyers have said.

Competition tensions elevate over ThyssenKrupp sale

Competition tensions elevate over ThyssenKrupp sale

28 January 2020

ThyssenKrupp’s anticipated sale of its elevator business has already raised antitrust concerns, as market players warn that a sale to rival Kone would result in a presumptively anticompetitive four-to-three merger.

Airlines attack Sabre/Farelogix deal

Airlines attack Sabre/Farelogix deal

GCR USA - 28 January 2020

The Department of Justice’s antitrust division began its case against travel technology company Sabre’s acquisition of Farelogix yesterday by bringing the companies’ customers to testify.

FTC loses bid to stall Evonik/PeroxyChem

FTC loses bid to stall Evonik/PeroxyChem

GCR USA - 28 January 2020

A federal judge has refused to grant a preliminary injunction against the proposed merger of two chemical companies, but the Federal Trade Commission’s challenge to the deal remains pending in its administrative tribunal.

The stuff of nightmares: The Tipline for 28 January 2020

GCR USA - 28 January 2020

The Antitrust Division opened its case against Sabre/Farelogix yesterday, calling as witnesses two airline executives who attacked the deal in no uncertain terms. United Airlines executive Tye Radcliffe said that when he heard about the merger he told others in the company it was “the stuff of nightmares but we’ll get through it”. We have Federal Trade Commission news as well: the agency brought a lawsuit with New York attorney general Letitia James against Vyera Pharmaceuticals, Martin Shkreli and another executive alleging the company blocked generic rivals from gaining access to samples.

McDonald’s ends exclusivity agreements in Israel

McDonald’s ends exclusivity agreements in Israel

27 January 2020

McDonald’s Israel has agreed to end exclusivity arrangements that prevented competitors from renting space in large shopping centres around the country.

Drugmaker admits pay-for-delay in UK

Drugmaker admits pay-for-delay in UK

27 January 2020

A pharmaceutical manufacturing company has confessed its involvement in a pay-for-delay agreement with Aspen.

Industrial strategy sets stage for European champions

Industrial strategy sets stage for European champions

27 January 2020

A leaked report has revealed the European Commission’s plan to amend competition rules so EU companies can better compete against foreign rivals.

Axon tries to short-circuit FTC process, US argues

Axon tries to short-circuit FTC process, US argues

GCR USA - 27 January 2020

A federal district court does not have jurisdiction over Axon’s challenge to the constitutionality of the Federal Trade Commission’s administrative process, the US government has argued.

Antitrust may not be drugmakers’ top policy concern

Antitrust may not be drugmakers’ top policy concern

GCR USA - 27 January 2020

As pharmaceutical companies lobby against bipartisan efforts to curb prescription drug prices, there may be room for competition-related bills to be signed into law.